MaseriA.From syndromes to specific disease mechanisms. Ital Heart J2000; 1: 253–7
2.
LusisA.Atherosclerosis. Nature2000; 407: 233–41
3.
RossR.Atherosclerosis—an inflammatory disease. N Engl J Med1999; 340: 115–26
4.
NicholsonAC, FebbraioM, HanJ, SilversteinRL, HajjarDP.CD36 atherosclerosis. The role of a class B macrophage scavenger receptor. Ann N Y Acad Sci2000; 90: 128–31
5.
Van BerkelTJ, Van EckM, HerijgersN, FluiterK, NionS.Scavenger receptor classes A and B. Their roles in atherogenesis and the metabolism of modified LDL and HDL. Ann N Y Acad Sci2000; 902: 113–26
6.
ZinggJM, RicciarelliR, AzziA.Scavenger receptor regulation and atherosclerosis. Biofactors2000; 11: 189–200
7.
FebbraioM, PodrezEA, SmithJDTargeted disruption of class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest2000; 105: 1049–56
8.
SuzukiH.A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature1997; 386: 292–6
9.
LiAC, BrownKK, SilvestreMJ, WillsonTM, PalinskiW, GlassCK.Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest2000; 106: 523–31
10.
NeveBP, FruchartJ, StaelsB.Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis. Biochem Pharmacol2000; 60: 1245–50
11.
BennettMR, LittlewoodTD, SchwartzSM, WeissbergPL.Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaques to p53-mediated apoptosis. Circ Res1997; 81: 591–9
12.
BennettMR, EvanGI, SchwartzSM.Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest1995; 95: 2266–74
13.
MachF, SchonbeckU, LibbyP.CD40 signaling in vascular cells: a key role in atherosclerosis?Atherosclerosis1998; 137(suppl): S89–S95
14.
LutgensE, CleutjensKB, HeenemanS, KotelianskyVE, BurklyLC, DaemenMJ.Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype [see comments]. Proc Natl Acad Sci USA2000; 97: 7464–9
15.
van der WalAC, PiekJJ, de BoerOJRecent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart1998; 80: 14–18
16.
DaneshJ, WhincupP, WalkerMChlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ2000; 321: 208–13
17.
AlberDG, PowellKL, VallanceP, GoodwinDA, Grahame-ClarkeC.Herpesvirus infection accelerates atherosclerosis in the apolipoprotein E-deficient mouse. Circulation2000; 102: 779–85
18.
DaneshJ, WhincupP, WalkerMLow grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ2000; 321: 199–204
19.
VallanceP, CollierJ, BhagatK.Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link?Lancet1997; 349: 1391–2
20.
BhagatK, MossR, CollierJ, VallanceP.Endothelial stunning following a brief exposure to endotoxin: a mechanism to link infection and infarction?Cardiovasc Res1996; 32: 822–9
LaitinenM, HartikainenJ, HiltunenMOCatheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty. Hum Gene Ther2000; 11: 263–70
23.
HoustonP, WhiteBP, CampbellCJ, BraddockM.Delivery and expression of fluid shear stress-inducible promoters to the vessel wall: applications for cardiovascular gene therapy. Hum Gene Ther1999; 10: 3031–44
24.
FayadZA, FusterV.Characterization of atherosclerotic plaques by magnetic resonance imaging. Ann N Y Acad Sci2000; 902: 173–86
25.
SkinnerMP, YuanC, MitsumoriLSerial magnetic resonance imaging of experimental atherosclerosis detects lesion fine structure, progression and complications in vivo. Nat Med1995; 1: 69–73
